Leadership Overview
Vitalant has 4 executives leading key functions including strategy, human capital, medical oversight, and regional operations.
Focused on advancing blood safety through rigorous scientific research, Vitalant maintains a commitment to evidence-based policies and global collaboration to improve patient outcomes across the transfusion medicine landscape.
Focused on advancing blood safety through rigorous scientific research, Vitalant maintains a commitment to evidence-based policies and global collaboration to improve patient outcomes across the transfusion medicine landscape.
Leadership Roles at Vitalant
Mike Fuller - Chief Executive Officer
Mike Fuller, the Chief Executive Officer at Vitalant, directs the overarching strategic vision for the organization. Overseeing the integration of scientific research with operational blood supply logistics, the Chief Executive Officer ensures alignment with long-term safety goals. This leadership role involves managing complex stakeholder relationships and driving innovation in transfusion medicine. By prioritizing evidence-based policies, Mike Fuller directly impacts the efficacy of the national blood supply chain. The Chief Executive Officer coordinates with the board to expand research capabilities in infectious diseases and cellular therapies. Through consistent focus on donor health and patient outcomes, the executive maintains the organization's position as a leader in the field. Ultimately, Fuller secures the financial and operational stability required to support global scientific collaborations and the training of future medical professionals across the entire enterprise.
James Dugger - Division President, Vitalant (South)
James Dugger, the Division President, Vitalant (South) at Vitalant, directs all operational activities and service delivery within the southern region. Overseeing the logistics of blood collection, processing, and distribution, the Division President, Vitalant (South) ensures the consistent availability of safe blood products for hospitals and patients. This leadership role involves managing regional infrastructure and optimizing supply chain efficiency to meet local healthcare demands. By aligning regional performance with the broader mission of the institute, James Dugger directly impacts the success of transfusion medicine initiatives in the southern market. The Division President, Vitalant (South) collaborates with research teams to implement new donor health protocols at the local level. Through the effective management of regional resources and staff, Dugger drives operational excellence and supports the organization's commitment to advancing blood safety across diverse communities.
Manuel Ocasio - Chief People Officer
Manuel Ocasio, the Chief People Officer at Vitalant, architects the human capital strategy necessary to support a massive, mission-driven workforce. Overseeing talent acquisition, organizational development, and employee engagement, the Chief People Officer ensures the company attracts top-tier scientific and medical talent. This leadership role involves fostering a culture of excellence that aligns with the institute's dedication to blood safety and transfusion medicine research. By implementing robust training programs, Manuel Ocasio directly impacts the retention of specialized staff capable of conducting pioneering studies in infectious diseases. The Chief People Officer collaborates with other executives to optimize workforce productivity across diverse geographic operations. Through the design of inclusive policies and performance management systems, Ocasio drives the organizational health required to sustain long-term growth and innovation in cellular therapies and donor health initiatives.

Paul Eastvold - Division Chief Medical Officer
Paul Eastvold, the Division Chief Medical Officer at Vitalant, directs the clinical standards and medical safety protocols governing blood transfusion services. Overseeing the application of evidence-based research to daily operations, the Division Chief Medical Officer ensures compliance with rigorous safety benchmarks. This leadership role involves managing medical teams that conduct studies in transfusion medicine and infectious disease prevention. By translating complex scientific findings into actionable clinical policies, Paul Eastvold directly impacts patient safety and donor health outcomes. The Division Chief Medical Officer coordinates with regional medical directors to maintain high standards across the national network. Through the continuous evaluation of cellular therapy protocols, Eastvold drives the integration of cutting-edge medical practices into the broader organizational framework. Ultimately, the Division Chief Medical Officer secures the clinical integrity of the blood supply through constant vigilance and expert medical oversight.
Explore Leadership Teams in Business Services
The American Institutes for Research (AIR) is one of the leading behavioral and social science research organizations in the world. Our overriding goal is to use the best science available to bring the most effective ideas and approaches to enhancing everyday life. For us, making the world a better place is not wishful thinking. It is the goal that drives us.Founded in 1946 as a not-for-profit organization, AIR is a carefully designed institution motivated by the desire to enhance the human experience. We are committed to contributing to the science of human behavior and the development of mans capacities and potential.Our work spans a wide range of substantive areas: education, student assessment, international education, individual and organizational performance, health research and communication, human development, usability design and testing, talent management, employment equity, and statistical and research methods. The intellectual diversity of our more than 1,800 employees, more than 50 percent of whom hold advanced degrees, enables us to bring together experts in many fields, including education, psychology, sociology, economics, psychometrics, statistics, public health, usability engineering, software design, graphics and video communicationsall in the search for innovative answers to any challenge.We conduct our work within a culture and philosophy of strict independence, objectivity, and non-partisanship, as we tackle societys most important issues.
Company Leadership
MM

GF
bioMerieux is a French multinational company specializing in in vitro diagnostics. It develops and manufactures innovative solutions for detecting infectious diseases, cancer, and other health conditions. The company provides instruments, reagents, software, and services that support clinical laboratories, healthcare professionals, and industrial clients worldwide.
Company Leadership QA
SM
PS
EP
Barrios Technology is a woman-owned aerospace business that has been providing high-quality engineering, software, and technology integration solutions for over 45 years. They serve both government and commercial space flight programs, including significant contributions to NASA's human spaceflight initiatives. Their services encompass space mission integration, software engineering, systems engineering, and data analytics solutions. Barrios is committed to innovation and advancing humanity, both on and off the planet, while also supporting local communities through STEM-focused initiatives.
Company Leadership CG
JC
KP
LG
Sai Life Sciences is a rapidly growing Contract Research, Development, and Manufacturing Organization (CRDMO) based in India. The company partners with pharmaceutical and biotechnology innovators to advance drug programs from discovery to commercial manufacturing, emphasizing scientific rigor and operational excellence. Their extensive capabilities include integrated drug discovery, drug substance development, and manufacturing of various modalities such as peptides and antibody-drug conjugates. Sai Life Sciences serves a diverse clientele, including some of the largest pharmaceutical companies across the US, UK, EU, and Japan.
Company Leadership RB
KK
